Intellia Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Intellia Therapeutics Inc
TickerNTLA
CIK #0001652130
CUSIP45826J105
SectorLife Sciences - In Vitro & In Vivo Diagnostic Substances
Address130 Brookline Street Suite 201, Cambridge, MA 02139
Source [EDGAR]
CIK Filing 2011 - 2024
[0001652130] 10-K
[0001652130] 10-Q
[0001652130] 3
[0001652130] 4
[0001652130] 5
[0001652130] 8-K
[0001652130] D
[0001652130] SC 13D
[0001652130] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
BlackRock Inc Intellia Therapeutics Inc [2023-01-25] 8.7
FMR LLC Intellia Therapeutics Inc [2022-02-09] 0.0
Nikko Asset Management Americas Inc Intellia Therapeutics Inc [2019-07-09] 11.29
Sumitomo Mitsui Trust Holdings Inc Intellia Therapeutics Inc [2019-07-09] 11.29
ARK Investment Management LLC Intellia Therapeutics Inc [2019-02-14] 15.67
State Street Corp Intellia Therapeutics Inc [2019-02-13] 5.3
Vanguard Group Inc Intellia Therapeutics Inc [2019-02-11] 6.32
BlackRock Inc Intellia Therapeutics Inc [2019-02-08] 6.6
Caribou Biosciences Inc Intellia Therapeutics Inc [2017-02-28] 0.0
Atlas Venture Fund IX LP Intellia Therapeutics Inc [2017-02-09] 12.3
FMR LLC Intellia Therapeutics Inc [2016-06-10] 0.0
OrbiMed Advisors LLC Intellia Therapeutics Inc [2016-05-20] 7.4
Regeneron Pharmaceuticals Inc Intellia Therapeutics Inc [2016-05-11] 7.7
Novartis Institutes for Biomedical Research Inc Intellia Therapeutics Inc [2016-05-11] 15.48
Form 3/4/5 Filer 2011 - 2024
Intellia Therapeutics, Inc.
Chase William J
Lebwohl David
Leonard John M
Goddard Glenn
Hicks Derek
Clark Eliana
Basta James
Sepp-Lorenzino Laura
Crowley John F
Bhanji Muna
Dorsa Caroline
Cohen Fred E
Keresty Georgia
Verwiel Frank
Goodman Jesse
Formela Jean Francois
Rivera Jose E
Schiermeier Andrew
Karsen Perry A
Novartis AG
Novartis Institutes for BioMedical Research, Inc.
Hayes John T
Bell Graeme
Caribou Biosciences, Inc.
Bermingham Nessan
Slaoui Moncef
Atlas Venture Associates IX, L.P.
Atlas Venture Fund IX, L.P.
Atlas Venture Associates IX, LLC
Gordon Carl L
Barnes Thomas M.
Heifner Nicole
Morrissey David V
Isaly Samuel D
OrbiMed Advisors LLC
OrbiMed Global Healthcare GP LLC
OrbiMed Capital GP V LLC
Fullerton Management Pte Ltd
Temasek Holdings (Private) Ltd
TLS Beta Pte. Ltd.
Temasek Life Sciences Private Ltd
Haurwitz Rachel E.
Caribou Therapeutics Holdco, LLC
Baker Julian
Baker Bros Advisors LP
Baker Felix
Baker Bros. Advisors (GP) LLC
Srivastava Sapna
Foresite Capital Management III, LLC
Foresite Capital Fund III, L.P.
Tananbaum James B.
Form 13F Holdings
Firm Period DFND Voting Shares
ARK Investment Management LLC [2023-03-31] SOLE 8,951,987.0 9,837,166.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 7,940,602.0
BlackRock Inc. [2023-03-31] SOLE 7,189,858.0 7,348,294.0
State Street Corp [2023-03-31] DFND 3,349,996.0 3,539,638.0
Sumitomo Mitsui Trust Holdings, Inc. [2023-03-31] DFND 3,112,964.0 3,112,964.0
Nikko Asset Management Americas Inc [2023-03-31] SOLE 2,735,487.0 3,112,964.0
Wellington Management Group LLP [2023-03-31] DFND 0.0 2,966,140.0
Morgan Stanley [2023-03-31] DFND 2,247,348.0 2,655,483.0
Federated Hermes Inc [2023-03-31] DFND 2,020,079.0 2,020,079.0
Price T Rowe Associates Inc /MD/ [2023-03-31] SOLE 355,014.0 1,794,087.0
AllianceBernstein LP [2023-03-31] DFND 1,635,970.0 1,764,928.0
Geode Capital Management LLC [2023-03-31] DFND 1,655,391.0 1,655,391.0
Viking Global Investors LP [2023-03-31] SOLE 1,569,545.0 1,569,545.0
Rokos Capital Management LLP [2023-03-31] OTR 0.0 1,389,296.0
Bank of America Corp /DE/ [2023-03-31] DFND 28,100.0 1,341,093.0
Casdin Capital LLC [2023-03-31] SOLE 1,275,000.0 1,275,000.0
Citadel Advisors LLC [2023-03-31] DFND 1,259,114.0 1,259,114.0
FMR LLC [2023-03-31] DFND 1,200,196.0 1,205,657.0
Himension Capital Singapore PTE Ltd [2023-03-31] SOLE 1,145,091.0 1,145,091.0
Nuveen Asset Management LLC [2023-03-31] DFND 1,058,068.0 1,058,218.0
Pictet Asset Management Sa [2023-03-31] DFND 1.0 940,496.0
Chevy Chase Trust Holdings, LLC [2023-03-31] DFND 0.0 937,066.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 869,172.0 869,172.0
Goldman Sachs Group Inc [2023-03-31] DFND 847,515.0 859,482.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 726,302.0 768,762.0
Northern Trust Corp [2023-03-31] DFND 50,761.0 759,739.0
Deep Track Capital LP [2023-03-31] SOLE 704,533.0 704,533.0
JPMorgan Chase & Co [2023-03-31] DFND 501,047.0 666,074.0
Bioimpact Capital LLC [2023-03-31] SOLE 572,459.0 572,459.0
Discovery Value Fund [2023-03-31] SOLE 561,561.0 561,561.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com